Communiqués Nightingale Health Oyj

Actions

HEALTH

FI4000490875

Marché Fermé - Nasdaq Helsinki Autres places de cotation 17:17:47 31/05/2024			Varia. 5j.	Varia. 1 janv.
1,73 ^EUR	+1,76 %		+2,06 %	+55,02 %

16/04	Nightingale Health ouvre un laboratoire aux États-Unis	CI
16/04	Nightingale Health et l'Englander Institute for Precision Medicine at Weill Cornell Medicine signent une lettre d'intention dans laquelle les parties conviennent de collaborer à l'adoption de la technologie propriétaire de Nightingale Health dans les soins de santé et la recherche médicale aux États-Unis	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nightingale Health's Board of Directors extended the subscription period of employee option rights	23/05	AQ
Nightingale Health launches new website aligned with the B2B and B2G strategy	21/05	AQ
Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million	25/04	AQ
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer	16/04	AQ
Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04	AQ
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04	AQ
Nightingale Health has completed the acquisition of Welltus Inc	29/03	AQ
Conversion of Nightingale Health Plc's EMP shares to Series B shares	20/03	AQ
Nightingale Health's technology used to analyze Uganda's General Population Cohort (GPC)	19/03	AQ
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03	AQ
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03	AQ
Nightingale Health's Half-year report: Healthcare implementations progressing in Finland and Singapore	07/03	AQ
Nightingale Health to publish half-year report for July - December 2023 on 7 March 2024	28/02	AQ
Nightingale Health receives regulatory approval for healthcare use from Health Sciences Authority in Singapore	23/02	AQ
Nightingale Health receives five new patents for its proprietary health risk detection capability	31/01	AQ
Nightingale Health joins Radical Health Festival Helsinki as Founding Partner to promote urgent global need for preventative health	19/01	AQ
Terveystalo begins using Nightingale Health's blood analysis technology in regular health checks in occupational health	02/01	AQ
Nightingale Health completes the analysis of all 500,000 UK Biobank samples creating the world's largest blood biomarker database for chronic disease research and prevention	13/12	AQ
Change in Nightingale Health Plc's Management Team	27/11	AQ
Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc	16/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Nightingale Health Oyj

Actions

HEALTH

FI4000490875

Communiqués

Filtres